A large case series shows that catheter ablation of refractory ventricular arrhythmia in patients with cardiogenic shock can allow for liberation from mechanical support in most cases.
The studies explore a novel catheter that delivers both pulsed-field and radiofrequency energy, a new method for mapping and ablating scar-related ventricular tachycardia, and high-power/short-duration ablation for atrial fibrillation.
In ablation of scar-related ventricular tachycardia, mapping the heart during activation from multiple directions promises to improve clinical outcomes, suggests the international Physio-VT trial.
Our electrophysiologists share their approach to deciding between ablation and medical management along with a wealth of insights for care before and after the ablation procedure.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Debate around findings of the multicenter CABANA study of ablation versus drug therapy for atrial fibrillation shouldn’t distract from why patients seek ablation in the first place: symptom relief.
Dr. Oussama Wazni suspects more patients with AF could benefit from early catheter ablation. So he’s leading two multicenter trials to see if his suspicions pan out.
Catheter ablation bested amiodarone for atrial fibrillation control in heart failure patients in a recent study. Here’s why a Cleveland Clinic electrophysiologist says it’s likely worth the risks in these patients.
One electrophysiology research project is showing potential in curbing radiation exposure during catheter ablation procedure in treatment of children with tachyarrhythmias. And it doesn’t compromise effectiveness.